Health Care & Hospitals This section contains releases covering every aspect of the health care industry, with special focus on hospitals and medical groups. Find information on upcoming medical and health care conferences, along with study results, policy changes, and news of advancements in the field. Also included are announcements of awards won by doctor, surgeons, and other health care providers as well as financial and company information regarding new appointments and partnerships, funding, quarterly reports, and legal news.

Latest

16:10 ET Regional Health Properties Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-Q

Regional Health Properties, Inc. ("Regional" or the "Company") (NYSE American: RHE) (NYSE American: RHEpA), a self-managed healthcare real...


16:05 ET Allergan Announces Updated Presentation Time at the Bernstein Strategic Decisions Conference

Allergan plc (NYSE: AGN) today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the Bernstein 35th Annual...


15:24 ET Samaritan's Purse Deploys Staff and Two Disaster Relief Units to Central U.S. Following Deadly Tornadoes, Flooding

Samaritan's Purse is on the ground in the Southern plains after the area was hit by dozens of devastating tornadoes and massive flooding. In...


15:24 ET The Risk of Relapse Increases During the Holidays For Those in Recovery

Ahead of the holiday, American Addiction Centers (NYSE: AAC) reminds people to keep their sober friends in mind during their weekend gatherings....


15:15 ET United States Specialty Generics Market Report 2019: $32.6 Bn Industry Trends, Share, Size, Growth, Opportunity and Forecasts 2011-2018 & 2019-2024

The "United States Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added...


14:58 ET Amgen annonce une offre publique d'achat au comptant recommandée aux actionnaires de Nuevolution

L'offre n'est pas faite et le présent communiqué de presse ne peut être distribué, directement ou indirectement, en Afrique du Sud, en...


14:45 ET Global Biomarkers Technologies, Markets, & Competitive Landscape to 2028 Featuring Profiles of 300+ Companies & 471 Collaborations

The "Biomarkers - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This...


14:45 ET FDA approves first PI3K inhibitor for breast cancer

Today, the U.S. Food and Drug Administration approved Piqray (alpelisib) tablets, to be used in combination with the FDA-approved endocrine...


14:35 ET Ovid Therapeutics realiza una presentación en la 12.ª edición del International Epilepsy Colloquium

Ovid Therapeutics Inc. (NASDAQ: OVID), empresa biofarmacéutica comprometida con el desarrollo de fármacos que transforman las vidas de personas ...


14:30 ET Cardiovascular Drug Delivery Markets, 2028

The "Cardiovascular Drug Delivery - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to...


14:23 ET Blue Cross Blue Shield of Massachusetts Releases Statement on Trump Administration's Proposed Rollback of Transgender Health Care Accommodations

In response to the Trump Administration's proposal to eliminate health care protections for transgender people, Andrew Dreyfus, president & CEO ...


14:15 ET Central Nervous System Diseases Drug Delivery Markets, 2028

The "Drug Delivery in Central Nervous System Diseases - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to...


13:57 ET Ovid Therapeutics donnera une conférence au 12e Colloque international sur l'épilepsie

Il s'agit de la première présentation scientifique des données d'innocuité et de tolérance du OV-935 (TAK-935) dans les encéphalopathies...


13:42 ET Masa Tsuchiya announces in-depth study on genomic mechanism for cell-fate change in the field of bioscience

In the research paper, they have conducted an extensive study on the general genomic mechanism that underlines the cell-fate change from embryo ...


13:21 ET AveXis Announces Innovative Zolgensma® Gene Therapy Access Programs for US Payers and Families

AveXis, a Novartis company, today announced innovative access programs for Zolgensma® (onasemnogene abeparvovec-xioi) for the treatment of...


13:19 ET Sanjay Gupta, M.D., Urges Graduates at Albert Einstein College of Medicine to "Do Good and Be Good"

Dr. Sanjay Gupta, CNN's chief medical correspondent, told graduates of Albert Einstein College of Medicine to embrace fear, savor opportunities ...


13:15 ET Global Chronic Kidney Disease Drugs Market to 2025 - Leading Players are AbbVie, Amgen, GlaxoSmithKline, Roche, and AstraZeneca

The "Chronic Kidney Disease Drugs Market - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The report...


13:14 ET REGENXBIO Announces First FDA Approval of a Gene Therapy Based on Its Proprietary NAV® Technology Platform

REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene...


13:09 ET AveXis receives FDA approval for Zolgensma®, the first and only gene therapy for pediatric patients with spinal muscular atrophy (SMA)

AveXis, a Novartis company, today announced the US Food and Drug Administration (FDA) has approved Zolgensma® (onasemnogene abeparvovec-xioi)...


13:00 ET Kimberly-Clark on a Mission for Period Progress on Menstrual Hygiene Day

Menstrual Hygiene Day is May 28 and Kimberly-Clark is engaging consumers, communities and employees in a global effort to improve access to...


12:59 ET Kim Sullivan named Chief Human Resources Officer for Encompass Health

Encompass Health (NYSE: EHC) today announced the appointment of Kim Sullivan as chief human resources officer, effective June 10. "After an...


12:48 ET Combined Insurance Recognized as a 'Best of the Best' Veteran-Friendly Company by U.S. Veterans Magazine

For the fifth consecutive year, Combined Insurance has been named a 'Best of the Best' veteran-friendly company by U.S. Veterans Magazine. A...


12:45 ET Accelerate Diagnostics to Present at the William Blair Growth Stock Conference on June 6, 2019

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced that Chief Executive Officer, Larry Mehren, and Chief Financial Officer, Steve...


12:34 ET Tomas Blomquist - New CEO & President of Biotage

Biotage AB (Biotage), (NASDAQ OMX Stockholm: BIOT.ST) – Biotage has appointed Tomas Blomquist as the new CEO and President of Biotage AB. Tomas ...


12:34 ET FDA approves innovative gene therapy to treat pediatric patients with spinal muscular atrophy, a rare disease and leading genetic cause of infant mortality

The U.S. Food and Drug Administration today approved Zolgensma (onasemnogene abeparvovec-xioi), the first gene therapy approved to treat...